| Pharmaceutical sector in Belgium | |
|---|---|
| Lead NCP | Belgium |
| Supporting NCP(s) | None Selected |
| Description | Specific instance notified by an NGO regarding the activities of a multinational enterprise operating in Belgium. |
| Theme(s) | Combating bribery, bribe solicitation and extortion, Competition, Consumer interests, Disclosure, General policies |
| Date | 24 Jan 2008 |
| Host country(ies) | Belgium |
| Source | NGO |
| Industry sector | Manufacturing |
| Status | Not accepted |
| Summary | In January 2008 the Belgian NCP received a request for review by an NGO alleging that a multinational pharmaceutical company had breached the general policies, disclosure, combating bribery, consumer interests and competition provisions of the Guidelines with its pricing of generic medication. After conducting an initial assessment the NCP issued a public statement (in French) on 4 July 2008 concluding that no further examination was needed. The allegations concerned a practice common to the entire pharmaceutical sector and the applicable legislation wasn't precise enough to charge the company with misconduct.
|
